juvenile-onset diabetes

(redirected from Type 1 diabetes mellitus)
Also found in: Dictionary, Thesaurus, Medical.
Related to Type 1 diabetes mellitus: Type 2 diabetes mellitus

juvenile-onset diabetes

[′jü·vən·əl ¦ȯn‚set ‚dī·ə′bēd·ēz]
(medicine)
A form of diabetes mellitus which develops early in life and presents much more severe symptoms than the more common maturity-onset diabetes.
References in periodicals archive ?
Global Diabetes Drug Market Overview - Global Diabetic Drug Clinical Pipeline by Company & Phase - Global Diabetic Drug Clinical Pipeline: 817 Drugs - Majority in Preclinical Phase: 205 Drugs - Type 2 Diabetes Mellitus Drugs in Pipeline: 380 Drugs - Type 1 Diabetes Mellitus Drugs in Pipeline: 79 Drugs - Diabetic Nephropathies Drugs in Pipeline: 41 Drugs - Marketed Diabetic Drugs: 99 Drugs
a) It is commonly associated with Type 1 Diabetes Mellitus
Osiris is developing the drug in partnership with the Juvenile Diabetes Research Foundation (JDRF) as a treatment for patients with newly diagnosed type 1 diabetes mellitus.
They acknowledge this connection is controversial as there are studies that fail to find associations, but begin with a description of the epidemiology, genetics and relation to immunology of Type 1 diabetes mellitus, and then describe human enterovirus infections in terms of their biological characteristics, molecular epidemiology, pathogenesis, immunity and clinical manifestations.
GENETIC INFLUENCE ON SUSCEPTIBILITY TO TYPE 1 DIABETES MELLITUS.
Type 1 Diabetes Mellitus Drug Clinical Pipeline by Company & Phase - Research to till Registered - Marketed Drug Clinical Insight
Most patients with type 1 diabetes have the immune-mediated form of type 1 diabetes mellitus with islet cell antibodies and often have other autoimmune disorders such as Hashimoto's thyroiditis, Addison's disease, vitiligo or pernicious anaemia.
Though, the results are not entirely new, the study contributes to the current knowledge on the factors associated with increase in carotid-intima media thickness in type 1 diabetes mellitus.
Down the road, the team will broaden its focus to include other autoimmune disorders with suspected environmental triggers, including rheumatoid arthritis, lupus, type 1 diabetes mellitus, multiple sclerosis, scleroderma (a thickening of the skin), and autoimmune thyroid disease.
The ACE Inhibitors in Diabetic Nephropathy Trialist Group: Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors?